Post by
prophetoffactz on Dec 20, 2022 9:25am
'Won't find a more full pipeline for a company this size'
Some very rough notes from presentation this morning...
Midatech was hoping for catalysts to do a financing:
Progression free surivivl trial but was delayed by regulators
Q-Sphera deal. couldn't get it over the line. big pharma march to own drummer
Hit:
worst financial market
tourist investors moved on to other sectors.
many biotechs trading below cash
financing extremely difficult.
went with BTI as best option
robust very valuble assets
6 products 6 indications
as platforms brought to proof of concept have a pipeline opportunity
multi-asset news flow
first patient glioblastoma was positive and patient recovering.
phase II could be enough for other indicatin one patient more to recruit in phase I
merged company won't find a more full pipeline for a company this size.
triial rare and orphan strategy regulators offer shortcuts and exclusivity
five platforms
100,000 X drug in the tumor
in screen of 83 drugs one of most effective.
DIPG median survival 26 months vs. 10 months. Surprisingly strong result
stat sig in mice
compelling results in human cell lines.
Comment by
emmitfitzhume on Dec 20, 2022 9:35am
"...after completion of the murder, I mean merger...." Dr. Deborah Rathjen. Freudian slip? Sure does feel like current shareholders are getting murdered....
Comment by
zwerp2000 on Dec 20, 2022 10:04am
Absolutely absurd. Stop trying to fool everyone with your irresponsible posts. The stock is $.03 US right now, Shareholders were burned bigtime by management. Game over. Move on. Nothing you've said over the years has remotely come true
Comment by
unclepieman on Dec 20, 2022 12:52pm
stop the pump, no one cares anymore
Comment by
unclepieman on Dec 20, 2022 4:15pm
No, actually I don't care. On my way out and I'll be burning this MF house down with my $. Enjoy